Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Sunovion’s Latuda Expanded Approval for Bipolar Depression in Pediatric Patients

biospaceMarch 07, 2018

Tag: FDA , Bipolar Depression

PharmaSources Customer Service